Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Pierre Fabre
Welcome,
Profile
Billing
Logout
24 Products
211 Diseases
24 Products
204 Trials
8846 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Mektovi
(binimetinib) / Ono Pharma, Pierre Fabre, Pfizer
Navelbine oral
(vinorelbine tartrate oral) / Pierre Fabre
Nerlynx
(neratinib) / Puma
Braftovi
(encorafenib) / Ono Pharma, Pierre Fabre, Pfizer
Savella
(milnacipran) / AbbVie, Pierre Fabre
Javlor
(vinflunine) / Pierre Fabre
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
Fetzima
(levomilnacipran ER) / Pierre Fabre, AbbVie
Beova
(vibegron) / Merck (MSD), Kissei, Kyorin, Sumitomo Pharma, Pierre Fabre
Condrosulf
(chondroitin sulfate) / IBSA Institute Biochemical SA, Pierre Fabre
TriptoSar
(omtriptolide) / Pierre Fabre
Tab-cel
(tabelecleucel) / Atara, Pierre Fabre
befiradol
(NLX-112) / Neurolixis
recombinant ectodysplasin A1
(APO200) / Valerio Therap, Pierre Fabre
ibuprofen lozenges
(V-0498) / Pierre Fabre
F17464
/ Pierre Fabre
V-0162
/ Pierre Fabre
F14512
/ Pierre Fabre
F373280
/ Pierre Fabre
STX-721
/ Scorpion Therap, Pierre Fabre
W0180
/ Pierre Fabre
exarafenib
(KIN-2787) / Pierre Fabre
lonigutamab
(VB421) / ValenzaBio, Pierre Fabre
lonigutamab ugodotin
(W0101) / Pierre Fabre, Roche
telisotuzumab
(h224G11) / AbbVie